Author

Hilda Tsai

Observed name: H Tsai

Institution: Roswell Park Comprehensive Cancer Center

Observed institution: Roswell Park Comprehensive Cancer Center

OpenAlex ID: A5072265729

Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies.

1999 · F Matsuno, Y Haruta, et al. · PubMed · 144

Endoglin-Targeted Cancer Therapy

2010 · Ben K. Seon, Akinao Haba, et al. · Current Drug Delivery · 135

Anti‐endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature

2009 · Shima Uneda, Hirofumi Toi, et al. · International Journal of Cancer · 76

Synergy between anti‐endoglin (CD105) monoclonal antibodies and TGF‐β in suppression of growth of human endothelial cells

2003 · Xinwei She, Fumihiko Matsuno, et al. · International Journal of Cancer · 62

Anti‐tumor activity of an anti‐endoglin monoclonal antibody is enhanced in immunocompetent mice

2008 · Masanori Tsujie, Tomoko Tsujie, et al. · International Journal of Cancer · 50

Effective anti-angiogenic therapy of established tumors in mice by naked anti-human endoglin (CD105) antibody: Differences in growth rate and therapeutic response between tumors growing at different sites

2006 · Masanori Tsujie, Shima Uneda, et al. · International Journal of Oncology · 38

Antiangiogenic chimeric anti-endoglin (CD105) antibody: pharmacokinetics and immunogenicity in nonhuman primates and effects of doxorubicin

2005 · Ken Shiozaki, Naoko Harada, et al. · Cancer Immunology Immunotherapy · 37

Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assay.

1997 · M Yoshida, R J Rybak, et al. · PubMed · 12

Abstract 378: Serum endoglin (CD105): Molecular heterogeneity and marked differences among different anti-endoglin monoclonal antibodies in the detection of metastasis and tumor progression

2010 · Naoko Harada, Norihiko Takahashi, et al. · Cancer Research · 1

Receptor-targeted anticancer therapy

2009 · Ben K. Seon, Yuro Haruta, et al. · Immunologic Research · 1

Differential expression of endoglin (CD105) between human malignant epithelial tissues and cultured epithelial cell lines

2007 · Tomoko Tsujie, Masanori Tsujie, et al. · Cancer Research · 1

Abstract 3278: Novel knock-in mice expressing human/mouse chimeric endoglin (ENG; CD105) develop normally and will be valuable for evaluating clinical application of anti-human ENG antibodies

2011 · Hirofumi Toi, Jill Duzen, et al. · Cancer Research

Suppression of growth of human malignant B cells by naked monoclonal antibodies that target ectoepitopes of the Igα/Igβ (CD79) component of the human B cell antigen receptor complex

2007 · Fumihiko Matsuno, Victor A. Filadora, et al. · Cancer Research

Works count: 13

Citation count: 557

H-index: 8

I10-index: 8